Free Trial

Dermata Therapeutics (DRMA) Institutional Ownership

Dermata Therapeutics logo
$6.02 +0.22 (+3.70%)
As of 03:54 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Dermata Therapeutics (NASDAQ:DRMA)

Current
Institutional Ownership
Percentage
8.67%
Number of
Institutional Buyers
(last 12 months)
1
Total
Institutional Inflows
(last 12 months)
$4.15M
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$519.60K
Get DRMA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Dermata Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

DRMA Institutional Buying and Selling by Quarter

Dermata Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/14/2025Armistice Capital LLC322,179$188K0.0%-21.6%50.498%
5/15/2025Armistice Capital LLC411,000$444K0.0%+1,411.0%6.813%
8/15/2024Armistice Capital LLC28,000$67K0.0%N/A4.982%
2/13/2024Armistice Capital LLC218,000$133K0.0%N/A6.158%
11/13/2023 Acadian Asset Management LLC75,538$79K0.0%+34.2%2.368%
8/7/2023 Acadian Asset Management LLC56,285$92K0.0%N/A2.405%
7/27/2023 Virtu Financial LLC32,105$53K0.0%N/A1.372%
11/7/2022 Virtu Financial LLC70,808$37K0.0%N/A0.701%
(Data available from 1/1/2016 forward)

DRMA Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of DRMA shares?

During the previous two years, the following institutional investors and hedge funds held shares of Dermata Therapeutics shares: Armistice Capital LLC ($188K), Acadian Asset Management LLC ($79K).Learn more on Dermata Therapeutics' institutional investors.

What percentage of Dermata Therapeutics' stock is owned by institutional investors?

8.67% of Dermata Therapeutics' stock is owned by institutional investors. Learn more on DRMA's institutional investor holdings.

Which institutional investors have been buying Dermata Therapeutics' stock?

The following institutional investors have purchased Dermata Therapeutics' stock in the last 24 months: Armistice Capital LLC ($629.80K), and Acadian Asset Management LLC ($19.25K).

How much institutional buying is happening at Dermata Therapeutics?

Institutional investors have bought a total of 383,800 shares in the last 24 months. This purchase volume represents approximately $4.15M in transactions.

Which of Dermata Therapeutics' major shareholders have been selling company stock?

The following institutional investors have sold Dermata Therapeutics stock in the last 24 months: Armistice Capital LLC ($88.82K).

How much institutional selling is happening at Dermata Therapeutics?

Institutional investors have sold a total of 88,821 shares in the last 24 months. This volume of shares sold represents approximately $519.60K in transactions.



This page (NASDAQ:DRMA) was last updated on 8/15/2025 by MarketBeat.com Staff
From Our Partners